TY  - GEN
AU  - Kastritis,E
AU  - Zervas,K
AU  - Symeonidis,A
AU  - Terpos,E
AU  - Delimbassi,S
AU  - Anagnostopoulos,N
AU  - Michali,E
AU  - Zomas,A
AU  - Katodritou,E
AU  - Gika,D
AU  - Pouli,A
AU  - Christoulas,D
AU  - Roussou,M
AU  - Kartasis,Z
AU  - Economopoulos,T
AU  - Dimopoulos,M A
TI  - Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG)
SN  - 1476-5551
PY  - 2009///0707
KW  - Age Factors
KW  - Aged
KW  - Analysis of Variance
KW  - Boronic Acids
KW  - therapeutic use
KW  - Bortezomib
KW  - Drug Evaluation
KW  - Female
KW  - Greece
KW  - Humans
KW  - Lenalidomide
KW  - Male
KW  - Multiple Myeloma
KW  - diagnosis
KW  - Neoplasm Staging
KW  - statistics & numerical data
KW  - Pyrazines
KW  - Retrospective Studies
KW  - Survival Rate
KW  - Thalidomide
KW  - analogs & derivatives
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1038/leu.2008.402
ER  -